Search information
Eiger BioPharmaceuticals, Inc.
Companies
"Audit"
Keywords
Tables in SEC filings
Source
Fiscal Year Ended | ||||||||
December 31, 2023 | December 31, 2022 | |||||||
Audit Fees(1) | $ | 1,097,400 | $ | 1,253,877 | ||||
Audit-related Fees(2) | — | — | ||||||
Tax Fees | — | — | ||||||
All Other Fees | — | — | ||||||
Total Fees | $ | 1,097,400 | $ | 1,253,877 |
Name | Audit | Compensation | Nominating and Governance | |||||||
Thomas Dietz, M.D., Ph.D. | Chair | ✓ | ✓ | |||||||
Jeffrey S. Glenn, M.D., Ph.D.* | ✓* | ✓* | Lisa Kelly-Croswell | ✓ | ||||||
Evan Loh, M.D. | Chair | ✓ | ||||||||
Christine Murray, M.S., R.A.C.** | ✓** | ✓** | ||||||||
Kim Sablich, M.B.A. | ✓ | Amit K. Sachdev, J.D. | ✓ | Chair | ||||||
Total meetings in 2023 | 4 | 7 | 3 |